Correction to "Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection"

ACS Omega. 2024 Jan 18;9(4):5082. doi: 10.1021/acsomega.3c10152. eCollection 2024 Jan 30.

Soledad Stagnoli¹, Gabriele Macari², Pietro Corsi², Barbara Capone², Ander Vidaurrazaga¹, June Ereño-Orbea^{3

4}, Ana Ardá³, Fabio Polticelli^{2

5}, Jesus Jimenez-Barbero^{3

4

6

7}, Nicola Ga Abrescia^{1

4

8}, Ivan Coluzza^{4

9}

¹ Structure and Cell Biology of Viruses Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.
² Department of Sciences, University of Rome Tre, 00154 Rome, Italy.
³ Chemical Glycobiology Laboratory, CIC bioGUNE, BRTA, 48160 Derio, Spain.
⁴ IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.
⁵ National Institute of Nuclear Physics, Roma Tre Section, 00154 Rome, Italy.
⁶ Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
⁷ Department of Organic & Inorganic Chemistry, Faculty of Science and Technology, University of the Basque Country, EHU-UPV, 48940 Leioa, Spain.
⁸ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
⁹ BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain.

Abstract

[This corrects the article DOI: 10.1021/acsomega.3c02921.].